Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A cancer-predisposing condition characterized by the development of colorectal cancer not associated with colorectal polyposis, endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinary tract cancer) that are frequently diagnosed at an early age.
Biomarker and diagnostic research for hereditary nonpolyposis colon cancer has been reported in the published literature.
17 clinical trials registered, 13 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 2 PHASE2, 2 PHASE1, 5 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05495776](https://clinicaltrials.gov/study/NCT05495776) |
Data assembled from 4 of 12 sources · Last updated Nov 3, 2026, 2:51 PM UTC
European rare disease database
Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
— |
State Scientific Centre of Coloproctology, Russian Federation |
RECRUITING |
[NCT03303833](https://clinicaltrials.gov/study/NCT03303833) | The GEOLynch Cohort Study | — | Wageningen University | RECRUITING |
[NCT07450612](https://clinicaltrials.gov/study/NCT07450612) | Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection | — | San Raffaele University | RECRUITING |
[NCT05411718](https://clinicaltrials.gov/study/NCT05411718) | A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome | PHASE2 | M.D. Anderson Cancer Center | RECRUITING |
[NCT06989814](https://clinicaltrials.gov/study/NCT06989814) | Smart Measurement of Circulating Tumor DNA | NA | Erasmus Medical Center | RECRUITING |
12 publications have been identified in PubMed for hereditary nonpolyposis colon cancer. Research spans Review / Meta-Analysis (27%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 27% |
Laboratory research | 3 | 27% |
Disease patterns and progression | 2 | 18% |
Other research | 1 | 9% |
Testing and diagnosis research | 1 | 9% |
Patient case studies | 1 | 9% |
Bhattacharya P (2026). [PMID: 28613748](https://pubmed.ncbi.nlm.nih.gov/28613748/). *Unknown Journal*. [Review / Meta-Analysis]
Sherman S (2026). [PMID: 33232092](https://pubmed.ncbi.nlm.nih.gov/33232092/). *Unknown Journal*. [Review / Meta-Analysis]
Mohiuddin M (2025). [PMID: 40978308](https://pubmed.ncbi.nlm.nih.gov/40978308/). *Health science reports*. [Epidemiology / Natural History]
Gómez-Molina R (2025). [PMID: 40612862](https://pubmed.ncbi.nlm.nih.gov/40612862/). *Oncology research*. [Review / Meta-Analysis]
Naeemi H (2025). [PMID: 41257893](https://pubmed.ncbi.nlm.nih.gov/41257893/). *Hereditary cancer in clinical practice*. [Diagnostic / Biomarker]
Eroglu S (2025). [PMID: 41463230](https://pubmed.ncbi.nlm.nih.gov/41463230/). *Cancers*. [Case Report / Case Series]
Hu E (2025). [PMID: 40957372](https://pubmed.ncbi.nlm.nih.gov/40957372/). *Stem cell research*. [Basic Science / Preclinical]
Saurborn E (2025). [PMID: 39949456](https://pubmed.ncbi.nlm.nih.gov/39949456/). *Cureus*. [Epidemiology / Natural History]
Huo M (2025). [PMID: 40116103](https://pubmed.ncbi.nlm.nih.gov/40116103/). *Discovery medicine*. [Basic Science / Preclinical]
Awosika JA (2025). [PMID: 40362635](https://pubmed.ncbi.nlm.nih.gov/40362635/). *International journal of molecular sciences*. [Basic Science / Preclinical]